Items Tagged ‘imaging’

June 13th, 2016

FDA Approves New Imaging Agent for Detection of Recurrent Prostate Cancer


The United States Food and Drug Administration (FDA) has approved Axumin (fluciclovine F 18), an radioactive agent, to be used in positron emission tomography (PET) imaging for the detection of recurrent prostate cancer. Prostate cancer is the second leading cause of cancer-related deaths among men in the United States. If prostate cancer recurs following initial […]

View full entry

Tags: Axumin, fluciclovine F 18, imaging, News, PET, Prostate Cancer, recurrence, Refactory/Recurrent Prostate Cancer, scan